Health Affairs June 1, 2024
Abstract
An oncology fellow shares her experience navigating a cancer drug shortage alongside her patient.
John was the first patient I met as a new medical oncology fellow in July 2022. He was a sturdy, stoic gentleman in his mid-fifties. He had served in the US Army Special Forces, and he was currently working as a certified nursing assistant at his local hospital.
In February 2021, John had been diagnosed with metastatic prostate cancer that had spread throughout his bones. Since that time, he had been followed in our medical oncology fellows’ clinic. He was currently on his fourth line of treatment, the oral antihormone medication abiraterone, along with the steroid prednisone. The oncology fellow who had previously been caring...
Today's Sponsors
Today's Sponsor